The principal objectives of this proposal are to elucidate the pathway used
by E. coli for recycling muropeptides, to determine the function recycling
serves in the life of the cell and to characterize the role of muropeptides
in the beta-lactamase induction process. These objectives follow from our
preliminary results which support the following tentative conclusions: (1)
AmpG, which is required for beta-lactamase induciton, is a permease
required for recycling cell wall components. (2) AmpG most likely
transports N-acetylglucosaminyl-beta 1-4, 1,6 anhydro-N-acetylmuramyl-L-
alanyl-D-glutamyl-(L)-meso-diaminopimelic acid (G1cNAc-anhMurNAc-L-ala-D-
glu-DAP) into the cytoplasm. (3) AmpD, required for beta-lactamase
inducibility is also essential for recycling. (4) ampD mutants accumulate
huge amounts of anhMurNAc-L-ala-D-glu-DAP indicating that it is an inducing
ligand. (5) AmpD is an anhMurNAc-1-ala amidase. Presumably the
tripeptide released by the AmpD amidase is added to UDPMurNAc by a yet to
be discovered tripeptide-adding enzyme thereby reintroducing L-ala-D-glu-
DAP into the biosynthetic pathway. (6) G1cNAc-anhMurNAC-L-ala-D-glu-DAP
is probably another inducer of beta-lactamase. Thus, based on these new
results of the past 16 months, the specific aims are:
1. To study and characterize the 4 predicted steps in the recycling
pathway, namely: AmpG permease, beta-N-acetylglucosaminidase, AmpD
amidase, and the hypothetical tripeptide-adding enzyme.
2. To identify the muropeptides involved in beta-lactamase induction and
to further characterize their role in beta-lactamase induction.
3. To search for a role of recycling in the life of the cell.
No Sub Projects information available for 5R01GM051610-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM051610-03
Patents
No Patents information available for 5R01GM051610-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM051610-03
Clinical Studies
No Clinical Studies information available for 5R01GM051610-03
News and More
Related News Releases
No news release information available for 5R01GM051610-03
History
No Historical information available for 5R01GM051610-03
Similar Projects
No Similar Projects information available for 5R01GM051610-03